Engy › Who's who in longevity › Alex Zhavoronkov
At a glance
- Alex Zhavoronkov: Founder of Insilico Medicine.
- Known for: AI for anti-ageing drug discovery.
- Channels/platforms: Research, media.
- Countries: Hong Kong/UAE.
Recent
- Study An open benchmark and language models for AI in aging biology
- Study Control theory of aging and longevity for gerotherapeutic drug discovery: state space, vector fields, modalities, safety, and the minimum safe cost of functional restoration
- Study Discovery of Highly Potent and Selective, Orally Bioavailable BTK-Targeting PROTACs Featuring Novel CRBN-Binding Warheads